Uterine Carcinosarcoma (MMMT) is a rare and aggressive type of cancer that affects the uterus. It is also known as malignant mixed Müllerian tumor (MMMT). This cancer is characterized by the presence of both carcinomatous (epithelial) and sarcomatous (mesenchymal) components.
Uterine carcinosarcoma typically arises in postmenopausal women, although it can occur in younger women as well. The exact cause of this cancer is unknown, but certain risk factors such as older age, prior radiation therapy, and a history of certain benign uterine conditions may increase the likelihood of developing it.
The symptoms of uterine carcinosarcoma may include abnormal vaginal bleeding, pelvic pain, and a mass or lump in the pelvic area. Diagnosis is usually made through a combination of imaging tests, biopsies, and histological examination.
Treatment for uterine carcinosarcoma often involves a combination of surgery, chemotherapy, and radiation therapy. The prognosis for this cancer is generally poor, as it tends to be aggressive and can spread to other parts of the body.
Regular check-ups and early detection are crucial in managing uterine carcinosarcoma. It is important to consult with a healthcare professional for personalized advice and treatment options.